Moderna (MRNA) Change in Acquisitions & Divestments (2018 - 2026)

Moderna (MRNA) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $732.0 million in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $732.0 million, up 6.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.6 billion (up 12.93% YoY), and the FY2025 annual result was $5.6 billion, changed 0.02% from the prior year.
• Change in Acquisitions & Divestments eased to $732.0 million in Q1 2026 per MRNA's latest filing, from $929.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $3.6 billion in Q3 2025 and troughed at -$539.0 million in Q3 2023.
• A 5-year average of $1.2 billion and a median of $1.1 billion in 2022 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments tumbled 89.79% in 2023, then jumped 306.31% in 2024.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $1.3 billion in 2022, then surged by 114.93% to $2.8 billion in 2023, then slumped by 67.93% to $914.0 million in 2024, then grew by 1.64% to $929.0 million in 2025, then retreated by 21.21% to $732.0 million in 2026.
• Business Quant data shows MRNA's Change in Acquisitions & Divestments at $732.0 million in Q1 2026, $929.0 million in Q4 2025, and $3.6 billion in Q3 2025.